EisenbergDM, KesslerRC, FosterC, NorlockFE, CalkinsDR, DelbancoTL. Unconventional medicine in the United States. Prevalence, costs, and patterns of use. N Engl J Med328: 246–252, 1993.
2.
BorkanJ, NeherJO, AnsonO, SmokerB. Referrals for alternative therapies. J Fam Pract39: 545–550, 1994.
3.
McLennanAH, WilsonDH, TaylorAW. Prevalence and cost of alternative medicine in Australia. Lancet347: 569–573, 1996.
4.
EisenbergDM, DavisRB, EttnerSL, AppelS, WilkeyS, Van RompayM, KesslerRC. Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. JAMA280: 1569–1575, 1998.
5.
SparberA, WoottonJC, BauerL, CurtG, EisenbergD, LevinT, SteinbergSM. Use of complementary medicine by adult patients participating in HIV/AIDS clinical trials. J Altern Complement Med6: 415–422, 2000.
6.
AstinJA. Why patients use alternative medicine: results of a national study. JAMA279: 1548–1553, 1998.
7.
JonasWB. Alternative medicine—learning from the past, examining the present, and advancing to the future. JAMA280: 1616–1618, 1998.
8.
FontanarosaPB, LundbergGD. Alternative medicine meets science. JAMA280: 1618–1619, 1998.
9.
CohenJJ. Reckoning with alternative medicine. Acad Med75: 571, 2000.
10.
BermanBM. Complementary medicine and medical education. BMJ322: 121–122, 2001.
11.
WetzelMS, EisenbergDM, KaptchukTJ. Courses involving complementary and alternative medicine at US medical schools. JAMA280: 784–787, 1998.
12.
WetzelMS, KaptchukTJ, HaramatiA, EisenbergDM. Complementary and alternative medicine: implications for medical education. Ann Intern Med138: 191–196, 2003.
13.
DevriesJM. Emerging educational needs of an emerging discipline. J Altern Complement Med5: 269–271, 1999.
14.
Fugh-BermanA, MyersA. Citrus aurantium, an ingredient of dietary supplements marketed for weight loss: current status of clinical and basic research. Exp Biol Med (in press).
15.
MarcusDM, GrollmanAP. Botanical medicines—the need for new regulations. N Engl J Med347: 2073–2076, 2002.
16.
BermanJD, StrausSE. Implementing a research agenda for complementary and alternative medicine. Annu Rev Med55: 239–254, 2004.
17.
HienTT. An overview of the clinical use of artemisinin and its derivatives in the treatment of falciparum malaria in Vietnam. Trans R Soc Trop Med Hyg88(Suppl 1):S7–S8, 1994.
18.
Van HensbroekMB, OnyiorahE, JaffarS, SchneiderG, PalmerA, FrenkelJ, EnwereG, ForckS, NusmeijerA, BennettS, GreenwoodB, KwiatkowskiD. A trial of artemether or quinine in children with cerebral malaria. N Engl J Med335: 69–75, 1996.
